Author:
Sagiv Oded,Debnam J. Matthew,Esmaeli Bita
Publisher
Springer International Publishing
Reference8 articles.
1. Esmaeli B. Ophthalmic oncology, vol. 6. Boston: Springer Science & Business Media; 2011.
2. Black EH, Nesi FA, Calvano CJ, Gladstone GJ, Levine MR, editors. Smith and Nesi’s ophthalmic plastic and reconstructive surgery. Springer Science & Business Media; 2012. Springer Science+Business Media, LLC, New York, USA.
3. Zhang P, Tang LJ, Gao HH, Zhang WX, Lin JX, Yang HS. Immunohistochemical features of carcinoma ex pleomorphic adenoma and pleomorphic adenoma in the lacrimal gland. Int J Ophthalmol. 2019;12(8):1238–42. https://doi.org/10.18240/ijo.2019.08.02. PMID: 31456912; PMCID: PMC6694048.
4. von Holstein SL, Fehr A, Persson M, Nickelsen M, Therkildsen MH, Prause JU, Heegaard S, Stenman G. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics. Ophthalmology. 2014;121(5):1125–33. https://doi.org/10.1016/j.ophtha.2013.11.037. Epub 2014 Jan 24. PMID: 24468654.
5. Andreasen S, von Holstein SL, Homøe P, Heegaard S. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma. Acta Ophthalmol. 2018;96(7):e768–71. https://doi.org/10.1111/aos.13667. Epub 2018 Feb 13. PMID: 29437290.